Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3501]

MS-553 shows promise in treating chronic lymphocytic leukaemia

Prof Jennifer Woyach - The Ohio State University, Columbus, USA

MS-553 shows promise in treating chronic lymphocytic leukaemia ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )

Enhancing cancer care in Africa: Patient perspectives and quality improvement

Dr Verna Vanderpuye - Korle-Bu Teaching Hospital, Accra, Ghana

Enhancing cancer care in Africa: Patient perspectives and quality improvement ( Dr Verna Vanderpuye - Korle-Bu Teaching Hospital, Accra, Ghana )

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and...

Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety ( Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA )

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML

Dr Akriti Jain - Cleveland Clinic, Cleveland, USA

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML ( Dr Akriti Jain - Cleveland Clinic, Cleveland, USA )

Consolidation treatment delays do not compromise survival in MRD-negative adult...

Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA

Consolidation treatment delays do not compromise survival in MRD-negative adult ALL ( Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA )

Multimodal AI model augments Oncotype DX in predicting distant recurrence in...

Dr Joseph Sparano - Icahn School of Medicine at Mount Sinai, New York, USA

Multimodal AI model augments Oncotype DX in predicting distant recurrence in HR+/HER2 node negative BC ( Dr Joseph Sparano - Icahn School of Medicine at Mount Sinai, New York, USA )

Higher tumour-infiltrating lymphocytes predict better pathologic response in...

Prof Sunil Badve - Emory University, Atlanta, USA

Higher tumour-infiltrating lymphocytes predict better pathologic response in HER2-positive breast cancer ( Prof Sunil Badve - Emory University, Atlanta, USA )

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in...

Dr Anjali Advani - Cleveland Clinic, Cleveland, USA

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL ( Dr Anjali Advani - Cleveland Clinic, Cleveland, USA )

Blinatumomab plus chemotherapy shows manageable toxicity in adults with Ph- B...

Dr Anjali Advani - Cleveland Clinic, Cleveland, USA

Blinatumomab plus chemotherapy shows manageable toxicity in adults with Ph- B-ALL ( Dr Anjali Advani - Cleveland Clinic, Cleveland, USA )

Ropeginterferon alfa-2b is evaluated as a disease-modifying option in essential...

Prof Jean-Jacques Kiladjian - Hôpital Saint-Louis, Paris, France

Ropeginterferon alfa-2b is evaluated as a disease-modifying option in essential thrombocythemia ( Prof Jean-Jacques Kiladjian - Hôpital Saint-Louis, Paris, France )

New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights...

Dr Xiaoming Zhong - St. Jude Children's Research Hospital, Memphis, USA

New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights blinatumomab benefits in key high-risk molecular types ( Dr Xiaoming Zhong - St. Jude Children's Research Hospital, Memphis, USA )

Tec-Dara significantly improves PFS and OS compared to SoC in relapsed...

Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA

$Tec-Dara significantly improves PFS and OS compared to SoC in relapsed/refractory multiple myeloma ( Dr Luciano Costa - University Of Alabama At Birmingham, Birmingham, USA )$

More from ecancer